Novavax (NVAX) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Novavax (NVAX) Tops Q4 EPS by 2c

Novavax Reports Fourth Quarter and Year-End 2016 Financial Results

February 27, 2017 4:05 PM EST

GAITHERSBURG, Md., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results for the fourth quarter and twelve months ended December 31, 2016.

Recent and Fourth Quarter Achievements:

Continued execution of the global Phase 3 Prepare clinical trial to prevent RSV in infants via maternal immunization. Prepare is a randomized, observer-blinded, placebo-controlled trial, conducted at multiple international sites. The primary objective is to determine the efficacy of maternal immunization with our RSV F Vaccine against symptomatic RSV lower respiratory tract infection with... More